search
Back to results

Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA

Primary Purpose

Osteoarthritis: Shoulder

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Interscalene brachial plexus block
bupivacaine extended-release liposome injection
Sponsored by
Rothman Institute Orthopaedics
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Osteoarthritis: Shoulder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

1. All individuals undergoing primary reverse and total shoulder arthroplasty by the shoulder service at Methodist Hospital or Rothman Specialty Hospital.

Exclusion Criteria:

  1. Psychiatric illness as defined by co-morbid diagnosis of bipolar disorder or schizophrenia
  2. Revision arthroplasty, arthroplasty for fracture
  3. Unable/unwilling to consent for enrollment
  4. Unable to complete postoperative pain survey
  5. Known adverse drug reaction or allergy to the medications used
  6. Chronic pain syndromes (including reflex sympathetic dystrophy, fibromyalgia, chronic diffuse musculoskeletal pain)
  7. Patients taking long acting narcotic pain medications (including extended release narcotic pain medications and methadone).
  8. Patients under the age of 18 years
  9. Patients with history of hepatic disease
  10. Pregnant women or women who are breastfeeding

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Active Comparator

    Active Comparator

    Arm Label

    interscalene brachial plexus block

    Bupivacaine extended-release liposome injection

    Arm Description

    Direct interscalene nerve block injection via brachial plexus

    Infiltration of local anesthetic/analgesic, Bupivacaine extended-release liposome injection (Exparel) + Diluted in 40cc of Saline into the capsule, subscapularis, deltoid, pectoralis major and subcutaneous tissues.

    Outcomes

    Primary Outcome Measures

    Morphine and Morphine Equivalent consumption

    Secondary Outcome Measures

    Full Information

    First Posted
    February 22, 2016
    Last Updated
    February 24, 2016
    Sponsor
    Rothman Institute Orthopaedics
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02695758
    Brief Title
    Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA
    Official Title
    Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing Shoulder Arthroplasty (TSA): A Randomized Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    February 2016
    Overall Recruitment Status
    Completed
    Study Start Date
    December 2014 (undefined)
    Primary Completion Date
    December 2015 (Actual)
    Study Completion Date
    undefined (undefined)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Rothman Institute Orthopaedics

    4. Oversight

    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    A non-blinded randomized controlled trial, in which participants undergoing primary reverse or total shoulder arthroplasty are randomly assigned to one of two treatment groups.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Osteoarthritis: Shoulder

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    156 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    interscalene brachial plexus block
    Arm Type
    Active Comparator
    Arm Description
    Direct interscalene nerve block injection via brachial plexus
    Arm Title
    Bupivacaine extended-release liposome injection
    Arm Type
    Active Comparator
    Arm Description
    Infiltration of local anesthetic/analgesic, Bupivacaine extended-release liposome injection (Exparel) + Diluted in 40cc of Saline into the capsule, subscapularis, deltoid, pectoralis major and subcutaneous tissues.
    Intervention Type
    Procedure
    Intervention Name(s)
    Interscalene brachial plexus block
    Intervention Type
    Procedure
    Intervention Name(s)
    bupivacaine extended-release liposome injection
    Primary Outcome Measure Information:
    Title
    Morphine and Morphine Equivalent consumption
    Time Frame
    24 hours following surgery

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: 1. All individuals undergoing primary reverse and total shoulder arthroplasty by the shoulder service at Methodist Hospital or Rothman Specialty Hospital. Exclusion Criteria: Psychiatric illness as defined by co-morbid diagnosis of bipolar disorder or schizophrenia Revision arthroplasty, arthroplasty for fracture Unable/unwilling to consent for enrollment Unable to complete postoperative pain survey Known adverse drug reaction or allergy to the medications used Chronic pain syndromes (including reflex sympathetic dystrophy, fibromyalgia, chronic diffuse musculoskeletal pain) Patients taking long acting narcotic pain medications (including extended release narcotic pain medications and methadone). Patients under the age of 18 years Patients with history of hepatic disease Pregnant women or women who are breastfeeding

    12. IPD Sharing Statement

    Learn more about this trial

    Local Intraoperative Analgesic Injection Versus Single Injection Interscalene Nerve Block in Patients Undergoing TSA

    We'll reach out to this number within 24 hrs